La Jolla, CA, United States of America

Corey M Dambacher

This inventor holds 15 USPTO granted patents and 9 published patent applications, plus 8 CIPO patents and 6 EPO patents, primarily in Nucleic Acid Sequencing. Top assignees: Omniome, Inc., Pacific Biosciences of California, Inc., Illumina Cambridge Limited. Active years: 2018-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Corey M Dambacher. Retrieved from https://idiyas.com/inventor/corey-m-dambacher

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 15 

% Patents Active = 100.0

 

 

Average Co-Inventor Count = 2.5

ph-index = 4

Forward Citations = 78(Granted Patents)


Location History:

  • La Jolla, CA (US) (2018 - 2022)
  • San Diego, CA (US) (2021 - 2023)

Company Filing History:


Years Active: 2018-2026

Loading Chart...
Loading Chart...
Loading Chart...
Areas of Expertise:
Nucleic Acid Sequencing
Polymerases
Binding Assay
Nucleotide Detection
Allele-Specific Capture
Genotyping
Complex Stabilization
Chemical Modification
Ternary Complexes
Detection Methods
15 patents (USPTO):Explore Patents

Title: Corey M Dambacher: Innovating Molecular Detection and Analysis

Introduction:

Corey M Dambacher, an accomplished inventor and researcher, is based in La Jolla, California. With a total of 12 patents to his name, he has made significant contributions in the field of molecular detection and analysis. Currently employed at Omniome, Inc., he continues to push the boundaries of scientific innovation.

Latest Patents:

One of Corey M Dambacher's notable inventions is the "Method and system employing distinguishable polymerases for detecting ternary complexes and identifying cognate nucleotides." This patent involves a method for identifying cognate nucleotides that are crucial in correctly sequencing primed template nucleic acid molecules. By utilizing a single imaging step, different cognate nucleotides can be identified for a collection of primed template nucleic acid molecules.

Another groundbreaking patent by Dambacher is the "Simultaneous background reduction and complex stabilization in binding assay workflows." This invention proposes a method and apparatus to separate solution-phase components surrounding an immobilized multicomponent complex while stabilizing the association of the components within the complex. This technique enables a reduction in background signal interference, leading to enhanced detection of the multicomponent complex.

Career Highlights:

Throughout his career, Corey M Dambacher has consistently demonstrated his expertise in molecular detection and analysis. His patents showcase his exceptional problem-solving abilities and commitment to advancing scientific techniques in genomics and molecular biology. These innovations have the potential to revolutionize how researchers approach sequencing and binding assays, offering improved accuracy and efficiency.

Collaborations:

Corey M Dambacher has collaborated with esteemed individuals in his field, including Eugene Tu and Joseph Franklin Rokicki. These collaborations have likely resulted in fruitful knowledge exchange and further advancements in their respective research areas. Working alongside other talented professionals is invaluable in driving innovation and pushing the boundaries of scientific discovery.

Conclusion:

Corey M Dambacher's contributions to the field of molecular detection and analysis are commendable. With his patents enabling improved methods for sequencing and binding assays, he is playing a key role in shaping the future of genomics research. With his current position at Omniome, Inc., one can expect him to continue making breakthroughs and driving innovation in his field.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…